Health
Prior SARS-CoV-2 infection enhances Johnson and Johnson Ad26.COV2.S vaccine immunogenicity – News-Medical.Net
A new study reports that the Johnson and Johnson vaccine against COVID-19 shows enhanced efficacy when administered to individuals…
A new study reports that the single-dose Johnson and Johnson Ad26.COV2.S vaccine against coronavirus disease 2019 (COVID-19) shows enhanced efficacy when administered to individuals with pre-existing antibodies against the severe acute respiratory syndrome…
-
Noosa News23 hours agoNRL grand final quick hits: Reece Walsh creates magic after avoiding sin bin as Broncos survive Hunt, Reynolds injuries to win premiership
-
General22 hours agoHow the internet reacted to Brisbane Broncos winning the NRL grand final
-
General11 hours agoThree youths in police custody after fire at Ashley Youth Detention Centre in northern Tasmania
-
Noosa News14 hours agoNew playground equipment encourages children to learn through ‘risky play’